Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA199932
Max Phase: Preclinical
Molecular Formula: C42H44O11
Molecular Weight: 724.80
Molecule Type: Small molecule
Associated Items:
ID: ALA199932
Max Phase: Preclinical
Molecular Formula: C42H44O11
Molecular Weight: 724.80
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)O[C@@]1([C@@H]2/C(C)=C(/O)C(=O)C3=C(C)[C@@H](OC(=O)/C=C/c4ccc5ccccc5c4)C[C@@](O)([C@H]2OC(=O)c2ccccc2)C3(C)C)CO[C@@H]1CCO
Standard InChI: InChI=1S/C42H44O11/c1-24-31(51-33(45)18-16-27-15-17-28-11-9-10-14-30(28)21-27)22-42(49)38(52-39(48)29-12-7-6-8-13-29)35(25(2)36(46)37(47)34(24)40(42,4)5)41(53-26(3)44)23-50-32(41)19-20-43/h6-18,21,31-32,35,38,43,46,49H,19-20,22-23H2,1-5H3/b18-16+,36-25+/t31-,32+,35+,38-,41-,42+/m0/s1
Standard InChI Key: XTWBLKZLMFUGNO-WUKRARGESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 724.80 | Molecular Weight (Monoisotopic): 724.2884 | AlogP: 5.58 | #Rotatable Bonds: 9 |
Polar Surface Area: 165.89 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.28 | CX Basic pKa: | CX LogP: 5.18 | CX LogD: 5.17 |
Aromatic Rings: 3 | Heavy Atoms: 53 | QED Weighted: 0.14 | Np Likeness Score: 1.70 |
1. Huang Q, Kirikae F, Kirikae T, Pepe A, Amin A, Respicio L, Slayden RA, Tonge PJ, Ojima I.. (2006) Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents., 49 (2): [PMID:16420032] [10.1021/jm050920y] |
Source(1):